Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group

PURPOSE: Highly sensitized patients with a high level of panel reactive antibody (PRA) experience more episodes of antibody-mediated rejection (AMR) and poorer graft survival than non-sensitized patients. Rituximab is a well-known monoclonal anti-CD20 antibody that causes the depletion of B lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Young Hae, Huh, Kyu Ha, Kim, Yu Seun, Lee, Hyung Soon, Kim, Myoung Soo, Kim, Soo Jin, Kim, Hyun Jung, Kim, Soon Il, Joo, Dong Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373982/
https://www.ncbi.nlm.nih.gov/pubmed/22708094
http://dx.doi.org/10.4174/jkss.2012.82.6.335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373982/
https://www.ncbi.nlm.nih.gov/pubmed/22708094
http://dx.doi.org/10.4174/jkss.2012.82.6.335

Ejemplares similares